Primary osteoporosis without features of OI in children and adolescents: Clinical and genetic characteristics

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 6, 2012, Pages 1252-1261

  Laine, Christine M ^a,b   Koltin, Dror ^c   Susic, Miki ^c   Varley, Talia L ^c   Daneman, Alan ^c   Moineddin, Rahim ^d   Cole, William G ^c   Mäkitie, Outi ^a,b   Sochett, Etienne ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

BMD; Juvenile osteoporosis; LRP5; LRP6; PTHLH

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; GENOMIC DNA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; SOMATOMEDIN;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM HOMEOSTASIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPRESSION FRACTURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERCALCIURIA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5 GENE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6 GENE; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; PARATHYROID HORMONE RELATED PROTEIN GENE; PHENOTYPE; PRESCHOOL CHILD; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE RADIOGRAPHY; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; ALLELES; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; MIDDLE AGED; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84861225711     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35278     Document Type: Article

References (43)

1. Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F. 2008. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11: 6- 21.
2. Bianchi ML. 2007. Osteoporosis in children and adolescents. Bone 41: 486- 495.
3. Bisello A, Horwitz MJ, Stewart AF. 2004. Parathyroid hormone-related protein: An essential physiological regulator of adult bone mass. Endocrinology 145: 3551- 3553.
4. Brixen K, Beckers S, Peeters A, Nielsen TL, Wraae K, Piters E, Balemans W, Bathum L, Andersen M, Van Hul W, et al. 2006. Two polymorphisms in the gene encoding the low-density lipoprotein receptor-related protein-5 (LRP5) are associated with peak bone mass mainly in non-sedentary men of the Odense Androgen Study. Calcif Tissue Int 78: S34- S35.
5. Brown SD, Twells RCJ, Hey PJ, Cox RD, Levy ER, Soderman AR, Metzker ML, Caskey CT, Todd JA, Hess JF. 1998. Isolation and characterization of LRP6, a novel member of the low denisty lipoprotein receptor gene family. Biochem Biophys Res Commun 248: 879- 888.
6. Cheung MS, Glorieux FH. 2008. Osteogenesis Imperfecta: Update on presentation and management. Rev Endocr Metab Disord 9: 153- 160.
7. Chlebna-Sokol D, Rusinska A. 2001. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis. Endocr Regul 35: 201- 208.
8. Dent CE, Friedman M. 1965. Idiopathic juvenile osteoporosis. Q J Med 34: 177- 210.
9. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE. 2004. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74: 866- 875.
10. Ferrari SL, Deutsch S, Baudoin C, Cohen-Solal M, Ostertag A, Antonarakis SE, Rizzoli R, de Vernejoul MC. 2005. LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone 37: 770- 775.
11. Hartikka H, Makitie O, Mannikko M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB. 2005. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20: 783- 789.
12. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. 1994. The diagnosis of osteoporosis. J Bone Miner Res 9: 1137- 1141.
13. Kauffman RP, Overton TH, Shiflett M, Jennings JC. 2001. Osteoporosis in children and adolescent girls: Case report of idiopathic juvenile osteoporosis and review of the literature. Obstet Gynecol Surv 56: 492- 504.
14. Kiel DP, Ferrari SL, Cupples LA, Karasik D, Manen D, Imamovic A, Herbert AG, Dupuis J. 2007. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone 40: 587- 596.
15. Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Keen R, Langdahl BL, et al. 2004. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19: 1619- 1627.
16. Koay MA, Tobias JH, Leary SD, Steer CD, Vilarino-Guell C, Brown MA. 2007. The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcif Tissue Int 81: 1- 9.
17. Koh JM, Jung MH, Hong JS, Park HJ, Chang JS, Shin HD, Kim SY, Kim GS. 2004. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci 19: 407- 412.
18. Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, Conneally PM, Hui SL, Johnston CC, Peacock M, et al. 2005. Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 20: 75- 80.
19. Kubota T, Michigami T, Sakaguchi N, Kokubu C, Suzuki A, Namba N, Sakai N, Nakajima S, Imai K, Ozono K. 2008. LRP6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd. J Bone Miner Res 23: 1661- 1671.
20. Lau HH, Ng MY, Ho AY, Luk KD, Kung AW. 2005. Genetic and environmental determinants of bone mineral density in Chinese women. Bone 36: 700- 709.
21. Lau HH, Ng MY, Cheung WM, Paterson AD, Sham PC, Luk KD, Chan V, Kung AW. 2006. Assessment of linkage and association of 13 genetic loci with bone mineral density. J Bone Miner Metab 24: 226- 234.
22. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, et al. 2008. International society for clinical densitometry 2007 adult and pediatric official positions. Bone 43: 1115- 1121.
23. Liu G, Vijayakumar S, Grumolato L, Arroyave R, Qiao H, Akiri G, Aaronson SA. 2009. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 185: 67- 75.
24. Mani A, Radhakrishnan J, Wang H, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP. 2007. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278- 1282.
25. Miao D, Li J, Xue Y, Su H, Karaplis AC, Goltzman D. 2004. Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. Endocrinology 145: 3554- 3562.
26. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, et al. 2005. Osteoblast-derived PTHLH is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115: 2402- 2411.
27. Mäkitie O, Doria AS, Henriques F, Cole WG, Compeyrot S, Silverman E, Laxer R, Daneman A, Sochett EB. 2005. Radiographic vertebral morphology: A diagnostic tool in pediatric osteoporosis. J Pediatr 146: 395- 401.
28. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. 2001. Osteoporosis prevention, diagnosis, and therapy. JAMA 285: 785- 795.
29. Novak A, Dedhar S. 1999. Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56: 523- 537.
30. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, et al. 2008. Bone mineral density, osteoporosis, and osteoporotic fractures: A genome-wide association study. Lancet 371: 1505- 1512.
31. Rusinska A, Chlebna-Sokol D. 2006. Insulin-like growth factor-I and mineral metabolism markers in children with idiopathic decrease in bone mass. Clin Chim Acta 366: 257- 263.
32. Saarinen A, Valimaki VV, Valimaki MJ, Loyttyniemi E, Auro K, Uusen P, Kuris M, Lehesjoki AE, Makitie O. 2007. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone 40: 1006- 1012.
33. Scillitani A, Jang C, Wong BY, Hendy GN, Cole DE. 2006. A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young Caucasian women. Hum Genet 119: 416- 421.
34. Smith R. 1995. Idiopathic juvenile osteoporosis: Experience of twenty-one patients. Br J Rheumatol 34: 68- 77.
35. Soroko SB, Barrett-Connor E, Edelstein SL, Kritz-Silverstein D. 1994. Family history of osteoporosis and bone mineral density at the axial skeleton: The Rancho Bernardo Study. J Bone Miner Res 9: 761- 769.
36. Steelman J, Zeitler P. 2001. Osteoporosis in pediatrics. Pediatr Rev 22: 56- 65.
37. Stewart TL, Ralston SH. 2000. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166: 235- 245.
38. Superti-Furga A, Unger S, the Nosology Group of the International Skeletal Dysplasia Society. 2006. Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet Part A 143A: 1- 18.
39. Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, et al. 2004. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J Bone Miner Metab 22: 341- 345.
40. Urano T, Shiraki M, Usui T, Sasaki N, Ouchi Y, Inoue S. 2009. A1330V variant of the low-density lipoprotein receptor-related protein 5 (LRP5) gene decreases Wnt signaling and affects the total body bone mineral density in Japanese women. Endocr J 56: 625- 631.
41. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG. 2006. Common genetic variation of the low density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 21: 141- 150.
42. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, et al. 2008. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 299: 1277- 1290.
43. Zhang ZL, Qin YJ, He JW, Huang QR, Li M, Hu YQ, Liu YJ. 2005. Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in postmenopausal Chinese women. Acta Pharmacol Sin 26: 1111- 1116.